ALOX12B
Basic information
Region (hg38): 17:8072636-8087716
Links
Phenotypes
GenCC
Source:
- congenital non-bullous ichthyosiform erythroderma (Strong), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 2 (Strong), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 2 (Strong), mode of inheritance: AR
- lamellar ichthyosis (Supportive), mode of inheritance: AR
- congenital non-bullous ichthyosiform erythroderma (Supportive), mode of inheritance: AR
- self-healing collodion baby (Supportive), mode of inheritance: AR
- autosomal recessive congenital ichthyosis 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ichthyosis, congenital, autosomal recessive 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic | 11773004; 16116617; 20301593 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (19 variants)
- Autosomal recessive congenital ichthyosis 2 (12 variants)
- Lamellar ichthyosis (3 variants)
- Ichthyosis (2 variants)
- ALOX12B-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALOX12B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 22 | ||||
missense | 15 | 73 | 99 | |||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 13 | |||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 1 | 4 | 1 | 2 | 8 | |
non coding | 17 | 28 | 49 | |||
Total | 23 | 26 | 100 | 21 | 32 |
Highest pathogenic variant AF is 0.000132
Variants in ALOX12B
This is a list of pathogenic ClinVar variants found in the ALOX12B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-8072652-G-GT | Congenital ichthyosiform erythroderma | Uncertain significance (Jun 14, 2016) | ||
17-8072670-T-C | Autosomal recessive congenital ichthyosis 2 | Uncertain significance (Jan 12, 2018) | ||
17-8072705-G-A | Autosomal recessive congenital ichthyosis 2 | Benign (Jan 13, 2018) | ||
17-8072783-G-T | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072789-C-G | Uncertain significance (Sep 08, 2023) | |||
17-8072795-C-A | Autosomal recessive congenital ichthyosis 2 | Uncertain significance (Apr 27, 2017) | ||
17-8072811-T-C | Inborn genetic diseases | Uncertain significance (Jan 02, 2024) | ||
17-8072813-G-C | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072817-T-C | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072836-T-A | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072839-T-TGCGCTGGCGGATGTCGTGTGAGATCTGGTTCAG | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072841-C-A | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072841-C-T | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072842-G-T | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072854-C-CGT | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072864-CT-C | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072865-T-C | Inborn genetic diseases | Uncertain significance (Jan 23, 2024) | ||
17-8072877-T-G | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072890-C-CTAT | Uncertain significance (Sep 01, 2022) | |||
17-8072899-TC-T | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072911-C-T | Autosomal recessive congenital ichthyosis 2 | Uncertain significance (Jan 13, 2018) | ||
17-8072914-C-T | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) | ||
17-8072919-A-C | Autosomal recessive congenital ichthyosis 2 | Uncertain significance (Sep 26, 2019) | ||
17-8072936-G-C | Inborn genetic diseases | Uncertain significance (Apr 13, 2022) | ||
17-8072939-T-TC | Autosomal recessive congenital ichthyosis 2 | Pathogenic (Jan 07, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALOX12B | protein_coding | protein_coding | ENST00000319144 | 15 | 15068 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000756 | 0.999 | 125692 | 0 | 56 | 125748 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.40 | 326 | 406 | 0.804 | 0.0000238 | 4553 |
Missense in Polyphen | 103 | 157 | 0.65604 | 1751 | ||
Synonymous | 0.599 | 158 | 168 | 0.941 | 0.0000101 | 1395 |
Loss of Function | 3.63 | 12 | 35.2 | 0.340 | 0.00000169 | 400 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000170 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000265 | 0.000264 |
Middle Eastern | 0.000170 | 0.000163 |
South Asian | 0.000588 | 0.000555 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Mainly converts arachidonic acid to (12R)- hydroperoxyeicosatetraenoic acid/(12R)-HPETE and minor stereoisomers. In the skin, acts upstream of ALOXE3 on the lineolate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins. Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss. May also play a role in the regulation of the expression of airway mucins. {ECO:0000269|PubMed:21558561, ECO:0000269|PubMed:22441738, ECO:0000269|PubMed:9618483}.;
- Pathway
- Serotonergic synapse - Homo sapiens (human);Arachidonic acid metabolism - Homo sapiens (human);Etodolac Action Pathway;Ketoprofen Action Pathway;Ibuprofen Action Pathway;Rofecoxib Action Pathway;Acetylsalicylic Acid Action Pathway;Diflunisal Action Pathway;Leukotriene C4 Synthesis Deficiency;Acetaminophen Action Pathway;Celecoxib Action Pathway;Sulindac Action Pathway;Diclofenac Action Pathway;Ketorolac Action Pathway;Naproxen Action Pathway;Etoricoxib Action Pathway;Carprofen Action Pathway;Flurbiprofen Action Pathway;Fenoprofen Action Pathway;Antrafenine Action Pathway;Antipyrine Action Pathway;Lumiracoxib Action Pathway;Magnesium salicylate Action Pathway;Trisalicylate-choline Action Pathway;Nepafenac Action Pathway;Phenylbutazone Action Pathway;Lornoxicam Action Pathway;Salsalate Action Pathway;Tenoxicam Action Pathway;Tiaprofenic Acid Action Pathway;Tolmetin Action Pathway;Salicylic Acid Action Pathway;Salicylate-sodium Action Pathway;Oxaprozin Action Pathway;Valdecoxib Action Pathway;Nabumetone Action Pathway;Indomethacin Action Pathway;Meloxicam Action Pathway;Suprofen Action Pathway;Bromfenac Action Pathway;Mefenamic Acid Action Pathway;Arachidonic Acid Metabolism;Piroxicam Action Pathway;Metabolism of lipids;Synthesis of 12-eicosatetraenoic acid derivatives;Arachidonic acid metabolism;Metabolism;Fatty acid metabolism;IL23-mediated signaling events
(Consensus)
Intolerance Scores
- loftool
- 0.257
- rvis_EVS
- -0.62
- rvis_percentile_EVS
- 17.4
Haploinsufficiency Scores
- pHI
- 0.207
- hipred
- Y
- hipred_score
- 0.630
- ghis
- 0.557
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.389
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Alox12b
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein lipidation;sphingolipid metabolic process;positive regulation of gene expression;arachidonic acid metabolic process;lipoxygenase pathway;positive regulation of MAPK cascade;linoleic acid metabolic process;ceramide biosynthetic process;hepoxilin biosynthetic process;oxidation-reduction process;establishment of skin barrier;positive regulation of mucus secretion
- Cellular component
- cytosol
- Molecular function
- arachidonate 12-lipoxygenase activity;iron ion binding;protein binding;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;linoleate 9S-lipoxygenase activity